Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 18,755 | 15,211 | N/A | N/A |
| Marketable Securities | 16,008 | 1,498 | N/A | N/A |
| Receivables | 5,172 | 3,245 | N/A | N/A |
| Inventories | 4,316 | 3,702 | N/A | N/A |
| Other current assets | 0 | 797 | 0 | 0 |
| TOTAL | $45,253 | $24,452 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 4,546 | 3,280 | N/A | N/A |
| Other Non-Current Assets | 1,981 | 2,253 | 0 | 0 |
| TOTAL | $6,527 | $5,533 | $N/A | $N/A |
| Total Assets | $51,780 | $29,985 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 890 | 2,089 | 0 | 0 |
| Accrued Expenses | 5,309 | 3,552 | N/A | N/A |
| TOTAL | $11,614 | $9,343 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 4,917 | 4,895 | N/A | N/A |
| Deferred Revenues | 4,843 | 3,193 | N/A | N/A |
| Other Non-Current Liabilities | 2,023 | 2,145 | 0 | 0 |
| TOTAL | $6,940 | $7,041 | $N/A | $N/A |
| Total Liabilities | $18,555 | $16,384 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 774 | 574 | N/A | N/A |
| Retained earnings | -95,222 | -83,406 | N/A | N/A |
| TOTAL | $33,225 | $13,602 | $N/A | $N/A |
| Total Liabilities And Equity | $51,780 | $29,985 | $0 | $0 |